MYELOKATHEXIS

Clinical trials for MYELOKATHEXIS explained in plain language.

Never miss a new study

Get alerted when new MYELOKATHEXIS trials appear

Sign up with your email to follow new studies for MYELOKATHEXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Could a stem cell drug tame rare immune disease?

Disease control Recruiting now

This early-phase study tests whether Mozobil, a drug already used to boost stem cells for transplants, can safely raise white blood cell counts in people with WHIMS. WHIMS is a rare genetic condition that traps infection-fighting cells in the bone marrow, leading to frequent infe…

Matched conditions: MYELOKATHEXIS

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

MYELOKATHEXIS

Get alerted when new MYELOKATHEXIS trials appear

Could a stem cell drug tame rare immune disease?